Apical Periodontitis — Ethanolic Extract of Sapindus Mukorrossi as Final Endodontic Irrigant.
Citation(s)
Bloomfield SF, Miles GA The antibacterial properties of sodium dichloroisocyanurate and sodium hypochlorite formulations. J Appl Bacteriol. 1979 Feb;46(1):65-73.
Farhad AR, Barekatain B, Koushki AR The Effect of Three Different Root Canal Irrigant Protocols for Removing Smear Layer on the Apical Microleakage of AH26 Sealer. Iran Endod J. 2008 Summer;3(3):62-7. Epub 2008 Jul 10.
Kuçi A, Alaçam T, Yavas O, Ergul-Ulger Z, Kayaoglu G Sealer penetration into dentinal tubules in the presence or absence of smear layer: a confocal laser scanning microscopic study. J Endod. 2014 Oct;40(10):1627-31. doi: 10.1016/j.joen.2014.03.019. Epub 2014 May 10.
Thaha KA, Varma RL, Nair MG, Sam Joseph VG, Krishnan U Interaction between Octenidine-based Solution and Sodium Hypochlorite: A Mass Spectroscopy, Proton Nuclear Magnetic Resonance, and Scanning Electron Microscopy-based Observational Study. J Endod. 2017 Jan;43(1):135-140. doi: 10.1016/j.joen.2016.09.015. Epub 2016 Dec 6.
Violich DR, Chandler NP The smear layer in endodontics - a review. Int Endod J. 2010 Jan;43(1):2-15. doi: 10.1111/j.1365-2591.2009.01627.x. Review.
Ethanolic Extract of Sapindus Mukorossi as the Final Endodontic Irrigant.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
